Jozsef Dr Knoll

Jozsef Dr Knoll's AcademicInfluence.com Rankings

Jozsef Dr Knoll

Medical

#1637

World Rank

#1999

Historical Rank

Pharmacology

#148

World Rank

#184

Historical Rank

medical Degrees

Download Badge

Medical

Jozsef Dr Knoll's Degrees

PhD Pharmacology Semmelweis University

Why Is Jozsef Dr Knoll Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jozsef Dr Knoll's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Some puzzling pharmacological effects of monoamine oxidase inhibitors. (1972) (583)
The inhibitory effect of adenosine and related nucleotides on the release of acetylcholine (1976) (251)
The striatal dopamine dependency of life span in male rats. Longevity study with (−)deprenyl (1988) (229)
Evidence that acetylcholine released by gastrin and related polypeptides contributes to their effect on gastrointestinal motility. (1973) (199)
Deprenyl (selegiline): the history of its development and pharmacological action (1983) (176)
(-)-Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's disease. (1983) (145)
Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm study (1985) (138)
Striatal dopamine, sexual activity and lifespan. Longevity of rats treated with (-)deprenyl. (1989) (119)
Phenylisopropylmethylpropinylamine (E-250), a new spectrum psychic energizer. (1965) (113)
R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuron. (1987) (112)
The pharmacology of selegiline ((−)deprenyl). New aspects (1989) (109)
MONOAMINE OXIDASE AND ITS INHIBITION (1976) (109)
The effects of sympathetic nerve stimulation and guanethidine on parasympathetic neuroeffector transmission; the inhibition of acetylcholine release (1971) (105)
Novel (-)deprenyl-derived selective inhibitors of B-type monoamine oxidase. The relation of structure to their action. (1978) (103)
Presynaptic inhibition leading to disinhibition of acetylcholine release from interneurons of the caudate nucleus: Effects of dopamine, β-endorphin and d-Ala2-Pro5-enkephalinamide (1977) (96)
Effect of frequency of stimulation on the inhibition by noradrenaline of the acetylcholine output from parasympathetic nerve terminals (1971) (87)
Neuronal peptide (enkephalin) receptors in the ear artery of the rabbit. (1976) (80)
(-)Deprenyl (selegiline), a catecholaminergic activity enhancer (CAE) substance acting in the brain. (1998) (78)
Acetylcholine-releasing effect of gastrin and related polypeptides. (1972) (71)
Effect of lithium on acetylcholine release and synthesis. (1972) (67)
The pharmacology of (-)deprenyl. (1986) (64)
Does the B form selective monoamine oxidase inhibitor lose selectivity by long term treatment? (1979) (63)
Phenylethylamine and tyramine are mixed-acting sympathomimetic amines in the brain. (1996) (59)
The effect of repeated doses of (-) deprenyl on the dynamics of monoaminergic transmission. Comparison with clorgyline. (1986) (57)
Comparative pharmacological analysis of the optical isomers of phenyl-isopropyl-methyl-propinylamine (E-250). (1967) (57)
Pharmacological basis of the therapeutic effect of (−)deprenyl in age‐related neurological diseases (1992) (56)
The possible mechanisms of action of (-)deprenyl in Parkinson's disease (2005) (56)
Enhanced catecholaminergic and serotoninergic activity in rat brain from weaning to sexual maturity: rationale for prophylactic (-)deprenyl (selegiline) medication. (1995) (56)
Satietin: A highly potent anorexogenic substance in human serum (1979) (54)
(-)Deprenyl and (-)1-phenyl-2-propylaminopentane, [(-)PPAP], act primarily as potent stimulants of action potential-transmitter release coupling in the catecholaminergic neurons. (1996) (51)
(−)1‐(Benzofuran‐2‐yl)‐2‐propylaminopentane, [(−)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain (1999) (51)
The pharmacological basis of the beneficial effects of (-)deprenyl (selegiline) in Parkinson's and Alzheimer's diseases. (1993) (50)
The influence of naloxone on barbiturate anesthesia and toxicity in the rat. (1977) (47)
Sexual hormones terminate in the rat: the significantly enhanced catecholaminergic/serotoninergic tone in the brain characteristic to the post-weaning period. (2000) (45)
(–)Deprenyl‐Medication: A Strategy To Modulate the Age‐Related Decline of the Striatal Dopaminergic System (1992) (45)
Sexually low performing male rats die earlier than their high performing peers and (-)deprenyl treatment eliminates this difference. (1994) (42)
(-)Deprenyl (Selegiline): past, present and future. (2000) (42)
Inhibition by deprenyl of dopamine uptake in rat striatum: a possible correlation between dopamine uptake and acetylcholine release inhibition. (1979) (40)
(-)-Deprenyl a selective MAO "B' inhibitor, increases [3H]imipramine binding and decreases beta-adrenergic receptor function. (1983) (39)
The facilitation of dopaminergic activity in the aged brain by (−)deprenyl. A proposal for a strategy to improve the quality of life in senescence (1985) (36)
Structure-activity studies leading to (-)1-(benzofuran-2-yl)-2-propylaminopentane, ((-)BPAP), a highly potent, selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain. (2001) (36)
The pharmacological profile of (-)deprenyl (selegiline) and its relevance for humans: a personal view. (1992) (36)
L-deprenyl plus l-phenylalanine in the treatment of depression (2005) (35)
Long-lasting, true aphrodisiac effect of (-)-deprenyl in sexually sluggish old male rats. (1983) (35)
Antiaging compounds: (-)deprenyl (selegeline) and (-)1-(benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective highly potent enhancer of the impulse propagation mediated release of catecholamine and serotonin in the brain. (2006) (35)
Presynaptic inhibition of acetylcholine release by endogenous and exogenous noradrenaline at high rate of stimulation. (1970) (33)
The regular occurrence of thick filaments in stretched mammalian smooth muscle. (1971) (33)
Memories of my 45 years in research. (1994) (31)
The pharmacology of azidomorphine and azidocodeine (1973) (29)
Multiple, small dose administration of (-)deprenyl enhances catecholaminergic activity and diminishes serotoninergic activity in the brain and these effects are unrelated to MAO-B inhibition. (1994) (29)
The ejaculatory behavior of sexually sluggish male rats treated with (-)deprenyl, apomorphine, bromocriptine and amphetamine. (1986) (29)
Rationale for (-)deprenyl (selegiline) medication in Parkinson's disease and in prevention of age-related nigral changes. (1995) (28)
Chromatographic studies on the binding, action and metabolism of (-)-deprenyl. (1990) (27)
(-)-1-(Benzofuran-2-yl)-2-propylaminopentane enhances locomotor activity in rats due to its ability to induce dopamine release. (2001) (27)
Enhancer substances: selegiline and R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane [(-)-BPAP] enhance the neurotrophic factor synthesis on cultured mouse astrocytes. (2003) (26)
Nigrostriatal dopaminergic activity, deprenyl treatment, and longevity. (1990) (26)
The action of (-) deprenyl on monoamine turnover rate in rat brain. (1982) (25)
[History of deprenyl--the first selective inhibitor of monoamine oxidase type B]. (1997) (24)
Motimeter, a new sensitive apparatus for the quantitative measurement of hypermotility caused by psychostimulants. (1961) (24)
Studies on the central effects of (-)cathinone. (1979) (24)
(−)Deprenyl and (−)parafluorodeprenyl-treatment prevents age-related pigment changes in the substantia nigra. A TV-image analysis of neuromelanin (1992) (23)
Inhibitory effect of dopamine on acetylcholine release from caudate nucleus. (1977) (23)
Direct evidence that eseroline possesses morphine-like effects. (1982) (23)
The effect of number of stimuli and rate of stimulation on the inhibition by PGE1 of adrenergic transmission. (1973) (22)
The effects of PGE1 on responses to cardiac vagus nerve stimulation and acetylcholine release. (1973) (21)
Enantioselective synthesis and absolute configuration of (-)-1-(benzofuran-2-yl)-2-propylaminopentane, ((-)-BPAP), a highly potent and selective catecholaminergic activity enhancer. (2001) (21)
Effect of prostaglandin E1 on the cardiac transmembrane potentials. (1973) (21)
Enhancer Regulation/Endogenous and Synthetic Enhancer Compounds: A Neurochemical Concept of the Innate and Acquired Drives (2003) (21)
Analgesic profile of rimazolium as compared to different classes of pain killers. (1988) (21)
The pharmacology of 1-phenyl-2-propylamino-pentane (PPAP), a deprenyl-derived new spectrum psychostimulant. (1992) (21)
Inhibition of adrenergic neurotransmission by prostaglandin E1 (PGE1) in the rabbit ear artery (1976) (20)
Azidomorphine and rymazolium an approach to the ideal analgesic (1973) (20)
Inflammation and writhing syndrome inducing effect of PGE1, PGE2 and the inhibition of these actions. (1975) (19)
The Brain and Its Self: A Neurochemical Concept of the Innate and Acquired Drives (2005) (19)
Sexual performance and longevity (1997) (19)
The structure-action relationship and kinetics of some naloxone and naltrexone derivatives. (1976) (19)
STRUCTURE-ACTIVITY RELATIONSHIP OF SELECTIVE INHIBITORS OF MAO-B (1980) (18)
Effect of hemicholinium-3 on the release and net synthesis of acetylcholine in Auerbach's plexus of guinea pig ileum (1977) (18)
Extension of lifespan in mice treated with Dinh lang (Policias fruticosum L.) and (-)deprenyl. (1992) (18)
A pharmacological analysis elucidating why, in contrast to (-)-deprenyl (selegiline), alpha-tocopherol was ineffective in the DATATOP study. (2003) (17)
Critical role of MAO inhibition in Parkinson's disease. (1987) (17)
(-)Deprenyl — the MAO inhibitor without the ‘cheese effect’ (1979) (17)
Anorectic Agents and Satietin, an Endogenous Inhibitor of Food Intake (1982) (17)
On the dual nature of monoamine oxidase. (1978) (17)
The pharmacology of 14‐hydroxyazidomorphine (1975) (17)
Endogenous anorectic agents--satietins. (1988) (16)
An improved method for the preparation of highly purified satietin samples from human serum. (1982) (16)
Stimulation of the catecholaminergic and serotoninergic neurons in the rat brain by R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane, (-)-BPAP. (2002) (16)
High performing rats are more sensitive toward catecholaminergic activity enhancer (CAE) compounds than their low performing peers. (1996) (15)
Two kinds of opiate receptor. (1977) (15)
The Isolated Nictitating Membrane of the Cat (1978) (15)
Interaction of selective inhibitors of monoamine oxidase with pethidine in rabbits. (1977) (15)
Selective inhibition of the "B form" of monoamine oxidase. (1977) (14)
Analysis of the analgesic and anti-inflammatory effects of rimazolium, a pyrido-pyrimidine derivative, compared with that of prostaglandin synthesis inhibitors and morphine. (1985) (14)
HIGHLY SELECTIVE PEPTIDE-CHALONES IN HUMAN SERUM: A concept on the control of physiological functions by blood-borne selective inhibitors of neurochemical transmission (1980) (14)
Recycling gel chromatography of phenolic compounds. II. Numerical calculation of optimal number of cycles and resolution (1975) (14)
Kinetic parameters of a new narcotic agonist, azidomorphine. (1973) (14)
Effect of duration and frequency of stimulation on the presynaptic inhibition by α-adrenoceptor stimulation of the adrenergic transmission (2004) (14)
The action of enkephalins and enkephalin analogues on neurotransmission in the isolated nictitating membrane of the cat (1978) (13)
Satietin: endogenous regulation of food intake. (1982) (13)
The analysis of post-tetanic potentiation in guinea-pig ileum longitudinal muscle strip. (1982) (13)
1,6-Dimethyl-4-oxo-1,6,7,8,9,9a-hexahydro-4H-pyrido(1,2-a)- pyrimidine-3-carboxamide (Ch-127) protects against the intestinal damage in rats caused by two weeks' daily administration of indomethacin. (1987) (13)
Inhibition of the effects of LSD and p-bromo-methamphetamine (V-111) by p-chlorophenylalanine (1970) (12)
Presynaptic Modulation by Norepinephrine and Dopamine of Acetylcholine Release in the Peripheral and Central Nervous System (1978) (12)
A procedure for measuring neuromelanin in neurocytes by a TV-image analyser (1992) (11)
Adrenergic neuroeffector junctions sensitive and insensitive to the effect of PGE. (1974) (11)
The effect of various MAO-B inhibitors on rabbit arterial strip response to tyramine. (1988) (11)
Symposium on Analgesics (1976) (11)
Effect of prostaglandin E1 and indomethacin on responses of longitudinal muscle of guinea-pig ileum to cholecystokinin. (1979) (11)
Possible mechanism of the low tolerance capacity of azidomorphine and azidocodeine. (1974) (11)
Increase by enkephalin of acetylcholine release from striatal slices of the rat. (1978) (10)
Satietin: a centrally acting potent anorectic substance with a long-lasting effect in human and mammalian blood. (1982) (10)
The site and state of myosin in intestinal smooth muscle. (1973) (10)
Analysis of the effect of (-)-BPAP, a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain. (2003) (10)
The selectivity of the anorectic effect of satietin. II. Ineffectiveness of satietin on the water intake in food deprived rats. Effect of satietin in "conditioned aversion" paradigm. (1982) (10)
Longevity study with low doses of selegiline/(-)-deprenyl and (2R)-1-(1-benzofuran-2-yl)-N-propylpentane-2-amine (BPAP). (2016) (10)
Cross-tolerance between para-bromo-methamphetamine (V-111) and LSD-25. (1970) (10)
The theory of active reflexes : an analysis of some fundamental mechanisms of higher nervous activity (1969) (10)
Satietins, α1‐glycoproteins in human plasma with potent, long‐lasting and selective anorectic activity (1987) (10)
The L-DOPA-sparing effect of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride [(-)-BPAP] in reserpine-pretreated rats. (2003) (9)
[Bioavailability of isosorbide dinitrate and isosorbide-5-mononitrate under steady-state conditions]. (2008) (9)
Long-term administration of (-)deprenyl (selegiline), a compound which facilitates dopaminergic tone in the brain, leaves the sensitivity of dopamine receptors to apomorphine unchanged. (1986) (9)
Opiate and dopamine receptors in the isolated nictitating membrane of the cat. (1978) (9)
The pharmacology of N-substituted azidomorphines. (1977) (9)
The aphrodisiac effect of low doses of (-) deprenyl in male rats. (1982) (9)
1-(Benzofuran-2-yl)-2-(3,3,3-trifluoropropyl)aminopentane HCl, 3-F-BPAP, antagonizes the enhancer effect of (-)-BPAP in the shuttle box and leaves the effect of (-)-deprenyl unchanged. (2002) (9)
Role of B-Type Monoamine Oxidase Inhibition in the Treatment of Parkinson’s Disease (1986) (8)
Predictive values of pharmacological models to study opiate dependence (1975) (8)
Microelectrophysiological analysis of the cardiac effect of prostaglandin E2. (1974) (8)
Experimental studies on the higher nervous activity of animals. IV. A method for elaborating and studying active conditioned feeding reflex; experimental analysis of differences between active conditioned defensive and feeding reflexes. (1956) (8)
The inhibitory effect of dopamine on acetylcholine release (1974) (8)
The effect of some anti-ulcer agents on the early vascular injury of gastric mucosa induced by ethanol in rats. (1989) (8)
Psychomimetic methylamphetamine derivatives. (1966) (8)
Experimental studies on the higher nervous activity of animals. VI. Further studies on active reflexes. (1957) (8)
[Method for the study of the specific depressive effect of tranquilizers on the central nervous system]. (1958) (7)
The selectivity of the anorectic effect of satietin. III. The ineffectiveness of satietin on metabolic rate, body temperature and blood pressure. (1982) (7)
113 Reserpine: Modification of its tranquilizer effect and analysis of its central mode of action (1961) (7)
How Selegiline ((-)-Deprenyl) Slows Brain Aging (2012) (7)
Structure-activity relationship of some analogues of gastrin and cholecystokinin on intestinal smooth muscle of the guinea-pig (2004) (7)
The effect of PGE2 on contraction delay and velocity of the field stimulated guinea-pig vas deferens (1975) (7)
A longevity study with enhancer substances (selegiline, BPAP) detected an unknown tumor‐manifestation‐suppressing regulation in rat brain (2017) (6)
Circulatory, respiratory and antitussive effects of azidomorphine and related substances. (1974) (6)
Symposium on Pharmacological Agents and Biogenic Amines in the Central Nervous System: First Congress of the Hungarian Pharmacological Society, Budapest, 1971; Vol 1 (1973) (6)
An HPLC tracing of the enhancer regulation in selected discrete brain areas of food-deprived rats. (2003) (6)
Pharmacological studies on para-bromo-methamphetamine (V-111) and LSD. (1970) (6)
THE SPECIFIC ACTIVATION OF THE CNS AND ITS SIGNIFICANCE IN PSYCHOPHARMACOLOGICAL RESEARCH (1965) (6)
The selectivity of the anorectic effect of satietin. I. The ineffectiveness of satietin on behavioral tests. (1982) (6)
Experimental studies on the higher nervous activity of animals. V. The functional mechanism of the active conditioned reflex. (1956) (6)
Absorption, distribution and elimination of drotaverine. (1978) (6)
Symposium on Pharmacology of the Heart (1976) (6)
Acetylcholine release from isolated vas deferens of the rat (2004) (6)
Further proof that (−) deprenyl fails to facilitate mesolimbic dopaminergic activity (1993) (6)
The pharmacology of 1,6-dimethyl-3-carbethoxy-4-oxo-6,7,8,9-tetrahydrohomopyrimidazol-methylsulphate (MZ-144), a new, potent, non-narcotic analgesic. II. Toxicity and analgetic effect of MZ-144 compared to narcotic and non-narcotic analgesics. (1971) (6)
Effect of azidomorphine and related substances on the intestinal motility. (1974) (6)
THE CUMULATIVE NATURE OF THE RESERPINE EFFECT AND THE POSSIBILITIES OF INHIBITING CUMULATION PHARMACOLOGICALLY. (1964) (5)
The selectivity of the anorectic effect of satietin. IV. The ineffectiveness of satietin on the sexual performance of male CFY rats. (1982) (5)
The aphrodisiac effect of (-)deprenyl in male rats. (1990) (5)
Satietin, a blood-borne, highly selective and potent anorectic glycoprotein. (1985) (5)
Quantitative studies of the antagonism by naloxone and N-cyclopropylmethyl-norazido-dihydroisomorphine (CAM) of different opiates. (1982) (5)
Symposium on Pharmacology of Vinca Alkaloids (1976) (5)
Sixth Meeting of the ‘Italian League against Parkinson’s Disease and Extrapyramidal Disorders’ (1981) (5)
Morphin-prostigmin synergismus. (1950) (5)
Repeated administration of (-)deprenyl leaves the mesolimbic dopaminergic activity unchanged. (1990) (5)
Analysis of the Pharmacological Effects of Selective Monoamine Oxidase Inhibitors (2008) (5)
A new model for the study of opiate B-receptors: isolated splenic strip of the cat. (1981) (5)
Para-substituted amphetamines and brain serotonin. (1975) (5)
Satietin, a blood-borne anorectic glycoprotein, as the putative rate-limiting satiety signal in the negative feed-back of food intake (1984) (4)
Effect of (-)-para-fluoro-deprenyl on survival and copulation in male rats. (1992) (4)
Specific desensitition to PGE1 and PGE2 in guinea-pig ileum; evidence for a common receptor site. (1975) (4)
The EEG arousal reaction in rats with extinguishable and non-extinguishable conditioned reflexes (1961) (4)
EFFECT OF PRIMARY PROSTAGLANDINS AND PROSTACYCLIN ON CARDIAC TRANSMEMBRANE POTENTIALS (1980) (4)
Effect of verapamil and D 600 on cardiac transmembrane potentials. (1978) (4)
The pharmacology of 1,6-dimethyl-3-carbethoxy-4-oxo-6,7,8,9-tetrahydro-homopyrimidazol-methylsulphate (MZ-144), a new, potent, non narcotic analgesic. I. Some basic correlations between the chemical structure and activity of homopyrimidazol analgesics. Selection of MZ-144. (1971) (4)
Classification of opioid receptors in the nictitating membrane of the cat (1988) (4)
Satietin; a 50,000 dalton glycoprotein in human serum with potent, long-lasting and selective anorectic activity (2005) (4)
Satietin, a blood-borne glycoprotein in the regulation of food intake. (1985) (4)
Comparative effects of prostaglandin F2alpha and A2 on the cardiac transmembrane potentials. (1978) (4)
Molecular weight measurement of human satietin. (1984) (4)
Inhibition of neuromuscular transmission by prostaglandin E1 in the circular muscle of the guinea-pig vas deferens. (1976) (4)
Inhibitory Effect of (2R)-1-(1-Benzofuran-2-yl)-N-propylpentan-2-amine on Lung Adenocarcinoma (2019) (3)
Effects of selective monoamine oxidase (MAO) inhibitors on conditioned avoidance responses (CAR) of rats. (1979) (3)
[Medicamentous strategy for improving the quality of life in the senescence]. (1986) (3)
The effect of (-) deprenyl (selegiline) on different behavioral changes induced by dopamine agonists in the rat. (1988) (3)
The action of single and repeated doses of p-bromo-methamphetamine on the monoamine content and turnover rate in rat brain (1981) (3)
Enhancer Regulation of Dopaminergic Neurochemical Transmission in the Striatum (2022) (3)
Authors’ Index Vol. 10, 1973 (1973) (3)
SELECTIVE INHIBITORS OF MAO-B WITH DIFFERENT PHARMACOLOGICAL PROFILES (1980) (3)
Opiate agonists inhibit noradrenaline release via opiate B-receptors and N-cyclopropylmethylnorazidomorphine (CAM) blocks electrically evoked contractions via histamine in the mouse vas deferens. (1981) (3)
The anorectic effect of satietin is unrelated to carbohydrate metabolism (1985) (3)
The pharmacology of 1,6-dimethyl-3-carbethoxy-4-oxo-6,7,8,9-tetrahydro-homopyrimidazol-methylsulphate (MZ-144), a new, potent, non-narcotic analgesic. IV. The fate of MZ-144 within the organism. (1971) (3)
(-)Deprenyl (selegiline) is devoid of amphetamine-like behavioural effects in rats. (1992) (3)
(-)Deprenyl (selegiline) in Parkinson's disease: a pharmacologist's comment. (1996) (3)
Azidomorphines: a new family of potent analgesics with low dependence capacity. (1979) (3)
Synthesis of new analgetic homopyrimidazoles. (1972) (2)
[Analgesia and the inhibition of cholinesterase]. (1951) (2)
Inhibitory effects of prostaglandin E1 on responses of rabbit ear artery to nerve stimulation and on release of norepinephrine. (1976) (2)
Interaction between phenylalkylamine derivatives and reserpine. (1968) (2)
The anorexogenic effect of satietin in comparison to the effects of calcitonin, cholecystokinin and pGlu-His-GlyOH (1980) (2)
Serotonin-mediated behavior in rats chronically treated with (-) deprenyl. (1988) (2)
Selective inhibition of noradrenergic transmission in vascular smooth muscle. (1978) (2)
Symposium on Pharmacology of Catecholaminergic and Serotonergic Mechanisms (1976) (2)
The effect of prostaglandin E1 on acetylcholine release from the cat brain. (1979) (2)
The metabolism of azidomorphine in the rat. (1975) (2)
THE TYPE OF MAO IN THE NIGROSTRIATAL DOPAMINERGIC NEURONS OF THE RAT (1979) (2)
The role of metabolic factors in the interaction between opiates and homopyrimidazoles in the central nervous system (1980) (2)
Synthetic enhancer compounds, besides acting on biogenic amine system, influence the glutamate transmission and stress response (2020) (2)
A new sensitive method which unlike the Vogel test detects the anxiolytic effect of tofisopam. (1988) (2)
First Congress of the Hungarian Pharmacological Society (1973) (2)
Responses of forebrain neurons to the MAO-B blocker l-deprenyl (1995) (2)
The time-structure of the anorectic effect of satietin (1985) (2)
The pharmacology of 1,6-dimethyl-3-carbethoxy-4-oxo-6,7,8,9-tetrahydro-homopyrimidazol-methylsulphate (MZ-144), a new, potent, non-narcotic analgesic. 3. Analysis of the central and peripheric effects. (1971) (2)
Experimental analysis of the central effect of convulsive hydrazides. (1961) (2)
The history of (-)deprenyl the first selective inhibitor of type B monoamine oxidase (1997) (2)
Effect of prostacyclin on cardiac transmembrane currents. (1982) (2)
DEPRENYL INHIBITS DOPAMINE UPTAKE IN THE RAT STRIATUM IN VIVO (1980) (2)
Cannabinoids with an ether side chain. Synthesis. Solubilization ans analgesic properties (1985) (1)
Effect of prostaglandins E1 and F2 alpha on neuromuscular transmission in the frog sartorius muscle. (1977) (1)
Comparison of biological activities of enkephalin analogues in isolated organs. (1982) (1)
[Analysis of the mechanism of reserpine]. (1966) (1)
The isolated nictitating membrane of the cat. A new model for the study of narcotic analgesics. (1978) (1)
1-phaenyl-2-propyl-aminopentane. HCl (MK-306): A deprenyl-derived new spectrum psychostimulant (1990) (1)
1272 – HYPERPOLARIZATION OF SMOOTH MUSCLE CELLS INDUCED BY SODIUM PUMP ACTIVATION (1978) (1)
1,6-Dimethyl-4-oxo-1,6,7,8,9,9a-hexahydro-4H-pyrido [1,2-a] pyrimidine-3-carboxamide (Chinoin-127), a potent non-narcotic analgesic and antiinflammatory agent. (1979) (1)
[Effect of parasympathomimetics on analgesia]. (1951) (1)
Gas chromatographic studies of derivatives of celluline-like substances. (1974) (1)
THE DISCOVERY OF THE ENHANCER REGULATION IN THE MAMMALIAN BRAIN AND THE DEVELOPMENT OF THE SYNTHETIC ENHANCER SUBSTANCES A chance to significantly improve the quality and prolong the duration of human life (2016) (1)
Thick filaments in guinea pig vas deferens smooth muscle. (1973) (1)
[Relationship between the structure of amphetamines and their capacity of raising the metabolic rate and temperature]. (1973) (1)
The effect of dinh lang and (-)deprenyl on the survival rate of male rats. (1990) (1)
The fate of (−)1-(benzofuran-2-yl)-2-propylaminopentane · HCl, (−)-BPAP, in rats, a potent enhancer of the impulse-evoked release of catecholamines and serotonin in the brain (2002) (1)
COMPARATIVE EFFECT OF PROSTACYCLIN AND PRIMARY PROSTAGLANDINS ON CARDIAC TRANSMEMBRANE CURRENTS (1980) (1)
542 – THE INFLUENCE OF DIFFERENT NARCOTIC ANTAGONISTS ON BARBITURATE SLEEPING (1978) (1)
Symposium on Prostaglandins (1976) (1)
MODULATION OF NEUROTRANSMITTER RECEPTORS AND DRUG RECOGNITION SITES BY REPEATED DOSES OF (-)DEPRENYL (1986) (1)
Azidomorphines and homopyrimidazols: a new approach to the ideal analgetic. (1977) (1)
Differentiation of multiple analgesic opiate receptors. (1985) (1)
Symposium on pharmacology of learning and retention (1974) (1)
Absorption, distribution and elimination of azidomorphine and related substances. (1975) (1)
The fate of p-bromo-methylamphetamine (V-111) in the body. (1981) (1)
Antiphlogistic action and gastric mucosal protection (1988) (1)
Pharmacological evidence that the anxiolytic effect of tofisopam is related to a subgroup of benzodiazepine receptors (1988) (1)
[Preparation and study of the cardiotonic substance of the liver]. (1952) (1)
(-)Deprenyl — lack of inducing place preference conditioning in rats (1993) (1)
Drugs affecting the calcium-dependent slow depolarization mechanism of the cardiac cell membrane. (1982) (1)
Correlation between the status of striatal dopamine, sexual activity and life span in male rats. Longevity study with (-)deprenyl (1988) (1)
Drugs affecting the tetrodotoxin-sensitive ("fast") sodium mechanism in the cardiac cell membrane. (1982) (1)
The effect of para-halogenated amphetamines on brain monoamines. (1978) (1)
Comparison of the dependence capacity of amphetamine, MK-306 and (-)deprenyl. (1990) (1)
Dose-dependent effect of prostaglandins on cardiac transemenbrane potential. (1976) (1)
THE EFFECTS OF AZIDOMORPHINES ON THE OPIATE RECEPTOR(S) OF GUINEA-PIG ILEUM (1980) (1)
[Comparative studies on the inhibiting action of tranquilizers on the central nervous system]. (1959) (0)
Benefits of Selegiline in the Treatment of Alzheimer’s Disease (AD) (2012) (0)
Psycho-stimulating agents. (1987) (0)
Biochemical and behavioral evidences for the selective nigrostriatal action of (-)deprenyl (1990) (0)
Contents, Vol. 10, 1973 (1973) (0)
History and highlights of pharmacology in Hungary. (1976) (0)
The aphrodisiac effect of (-)deprenyl in non-copulator male rats (1988) (0)
The electrophysiological actions of adrenaline on guinea pig taenia coli smooth muscle (1978) (0)
The antitussive effects of azidomorphine and 14 hydroxy azidomorphine (1974) (0)
2275 – EFFECT OF BIOGENIC AMINES, PROSTAGLANDINS (PGs) AND CELLULINE-A ON CARDIAC TRANSMEMBRANE POTENTIALS (1978) (0)
Effect of prostaglandins and celluline-A on cardiac transmembrane currents (1976) (0)
Pyrimido (1,2-a) -heterocyclic compounds and their preparation and use (1976) (0)
Analgesic and antitussive effects of azidomorphine and azidocodeine derivatives (1976) (0)
4-oxo-4H-pyrido [1,2-a] pyrimidine-3-carboxamide derivatives, their preparation and pharmaceutical preparations containing these compounds and their preparation. (1989) (0)
Preparation of highly purified bovine liver angiohypotensin by HPLC (1992) (0)
346 – PROSTAGLANDIN E1 AND INTESTINAL MOTILITY (1977) (0)
The antagonistic action of new homopirimidazol derivatives on monoamino oxidation (Hungarian) (1974) (0)
Central nervous system stimulants and anorectic agents (1987) (0)
Benefits of Selegiline in the Treatment of Major Depression Disease (MDD) (2012) (0)
Analogifremgangsmaade for the preparation of 4-oxo-4H-pyridooe1,2-aaapyrimidiner or pharmaceutically acceptable acid addition salts or quaternary ammonium salts thereof (1978) (0)
Effect of para-substituted amphetamine derivatives on tryptophan hydroxylase activity (1977) (0)
Analysis of the mechanism of the action of the psychostimulant effect of 1-phenyl-2-propylaminopentane (PPAP). A comparison with amphetamine (1992) (0)
Further evidence that (-)deprenyl acts selectively on the striatal dopaminergic system (1988) (0)
Composition against motion sickness, its preparation and use (1988) (0)
[Role of protein binding in the synergism of analgesics and parasympathomimetics]. (1953) (0)
SYMPOSIUM ON CURRENT PROBLEMS IN THE PHARMACOLOGY OF ANALGETICS (1974) (0)
ENHANCER SUBSTANCES: (-)-DEPRENYL AND (-)-BPAP, SPECIFIC ENHANCERS OF THE BRAIN STEM NEURONS (2003) (0)
Drug effects on the sodium exchange diffusion of the heart (1974) (0)
Amphetamine-derived potent psychostimulants devoid of biogenic amine releasing properties (1988) (0)
(-)-Deprenyl(Selegiline), The First Selective Inhibitor of B-Type MAO and the Unique One Free of the Cheese Effect (2012) (0)
COMPARISON OF THE ANALGETIC ACTION OF INHIBITORS OF PG SYNTHESIS, CHINOIN-127 AND MORPHINE (1980) (0)
Pharmaceutical compositions therein detailed phenylalkylaminger or salts thereof and the compounds' preparation (1988) (0)
Effect of phenylethylamine and amphetamine on sympathetic nerve stimulation of the cat papillary muscle (1978) (0)
Symposium on Drugs and Heart Metabolism; First Congress of the Hungarian Pharmacological Society, Budapest, 1971; Vol 2 (1973) (0)
Effect of PGE2 on contractions of the guinea pig vas deferens elicited by lasting field stimulation (1978) (0)
The Age-Related Decline of Dopaminergic Activity and the Reason Why Low Dose of (-)-Deprenyl Slows Brain Aging and Prolongs Life (2012) (0)
Effect of verapamil on the cardiac transmembrane potentials (1974) (0)
The Catecholaminergic Activity Enhancer Effect of (-)-Deprenyl and R-(-)-1-(Benzofuran-2-yl)-2-Propylaminopentane [(-)-BPAP] (2012) (0)
[Regulation of the ionic equilibrium between cells and their surrounding liquids in isolated frog heart]. (1958) (0)
Synthesis and analgesic properties of some cannabinoids with ether type side chains (1986) (0)
ANGIOHYPOTENSIN: A SELECTIVE ENDOGENOUS INHIBITOR OF NEUROMUSCULAR TRANSMISSION IN VASCULAR SMOOTH MUSCLE (1979) (0)
p-Bromo-methamphetamine (V-III) induced improvement of learning ability in rats. (1975) (0)
3-amino-4-ethylthio-7-Cl-quinoline.HCl (EGIS 5278), a benzodiazepine receptor related new spectrum anxiolytic (1990) (0)
1541 – INHIBITION OF DOPAMINE UPTAKE IN THE RAT STRIATUM AS A POSSIBLE MECHANISM OF ACTION OF (-)DEPRENYL IN PARKINSON'S DISEASE (1978) (0)
Aphrodisiac action of selective monoamine oxidase inhibitors in male rats (1981) (0)
Tetrahydrohomopyrimidazolderivate whose acid-addition salts and quaternary salts and methods for their preparation (1967) (0)
Benefits of Selegiline in the Treatment of Parkinson’s Disease (PD) (2012) (0)
979 – COMPARATIVE EFFECTS OF CELLULINE-A AND PROSTAGLANDINS ON THE CARDIAC CELL MEMBRANE (1977) (0)
[Selective inhibitors of 2 types of monoamine oxidase and new possibilities of their therapeutic use]. (1982) (0)
Some behavioural effects of (-) and (+)deprenyl and amphetamine enantiomers: A comparative study (1992) (0)
Reduction of learned helplessness by (-)deprenyl (1993) (0)
Tripeptides, processes for preparing the same and pharmaceutical compositions containing them (1982) (0)
1479 – EVIDENCE OF AX0NAL FLOW OF ACH IN PREGANGLI0NIC TRUNK OF CERVICAL SYMPATHETIC NERVE (1977) (0)
Uptake of p-Br-methamphetamine stereoisomers (V-III) by tissues and their effect on uptake of biogenic amines (1976) (0)
194 – PHARMACOLOGICAL PROPERTIES OF AZIDOETHYLMORPHINE, A NEW POTENT, NONNARCOTIC ANTITUSSIVE (1978) (0)
SATIETIN: A HIGHLY POTENT ANOREXOGENIC SUBSTANCE IN MAMMALIAN BLOOD (1980) (0)
718 – ABSORPTION, DISTRIBUTION, ELIMINATION AND METABOLISM OF DEPRENYL (1978) (0)
The effect of prostaglandin E1 (PGE1) on the neurochemical transmission of the myocardium (Hungarian) (1973) (0)
New 7,8-dihydro-isomorphin derivatives and a process for their production (1974) (0)
2420 – PRESYNAPTIC RECEPTORS IN ELECTRICALLY STIMULATED STRIPS OF THE CAT SPLEEN (1978) (0)
[Experimental studies on the higher nervous activies of rats. III. Classification of active reflexes and discussion of the principles of study methods]. (1958) (0)
Novel optically active amino pentane derivative (1999) (0)
Propinylamine type monoamine oxidase (MAO) inhibitors (1977) (0)
Azidomorphines and heterogenous opiate receptors. (1988) (0)
[Effect of peptone on the action of analgesics and parasympathomimetics]. (1952) (0)
Effect of prostaglandin E1 on adrenergic transmission in isolated organs (1976) (0)
DIFFERENCES IN THE BEHAVIORAL EFFECTS OF DEPRENYL ENANTIOMERS (1992) (0)
3- (amino) quinoline-4- (thioether), processes for preparing the same and pharmaceutical compositions containing them (1988) (0)
RELATIONSHIPS BETWEEN THE SUGGESTED OPIOID RECEPTORS (1986) (0)
SENSITIVITY OF OPIATE RECEPTORS IN WITHDRAWAL SYNDROME (1980) (0)
Composition servant a traiter la schizophrenie (1989) (0)
2411 – FEEDBACK INHIBITORY EFFECT OF STIMULATION INDUCED NORADRENALINE (NA) RELEASE IN THE VAS DEFERENS OF THE RAT (1978) (0)
Inhibitory effect of morphine (Mo) and azidomorphine (AM) on the gastrointestinal effect of cholecystokinin and pentagastrin (1974) (0)
Distribution of 1,6-dimethyl-3-carbethoxy-4-oxo-6,7,8,9-tetrahydrohomopyrimidazole-methylsulphate (MZ-144, Probon). (1973) (0)
The role of metabolic factors in the interaction between opiates and homopyrimidazoles in the central nervous system. (1980) (0)
Elaboration of highly purified angiohypotensin preparations from mammalian liver. (1990) (0)
Influence on catecholaminergic and serotonergic systems by (−)deprenyl (1990) (0)
Effect of Li+ on cholinergic mechanisms of rat brain and superior cervical ganglion of the cat (1976) (0)
EFFECT OF p-BROMO-METHAMPHETAMINE /V-lll/ ON SEROTONERGIC AND CATECHOLAMINERGIC MECHANISMS (1980) (0)
Effect of cellulin-A and changes in ionic milieu on the transmembrane currents of the sino-auricular fibre of the frog (1977) (0)
Inflammation and "writing syndrome" inducing effects of PGE1 PGE2 and the inhibition of these actions. (1974) (0)
417 – NARCOTIC ANALGETICS AND ACETYLCHOLINE RELEASE IN THE CAT'S BRAIN (1977) (0)
192 Electroencephalographical discrimination between sedato-hypnotic and major tranquillizing effects in rats with non-extinguishable conditioned reflexes (1961) (0)
Conversions of tosyl and mesyl derivatives of the morphine group XVIII. 'Azidomorphine' derivatives, II (1977) (0)
Single, small dose administration of (-)methamphetamine (MA) and (-)deprenyl (D), in contrast to (+)MA enhances catecholaminergic activity and diminishes serotoninergic activity in the brain stem of rats (1995) (0)
Study of the mode of action of 'prostaglandin' E1 and E2 with the aid of the 'sucrose gap' in taenia coli preparations (Hungarian) (1973) (0)
[Positional labeling of Halidor by different radioisotopes and the use of isotope isomers in thin layer chromatography of metabolites]. (1973) (0)
Effect of hyposmotic shock (HS) on acetylcholine (ACh) release and ACh content of Auerbach's plexus (1978) (0)
Pyrido-pyrimidines — with analgesic and anti-inflammatory activity — inhibit the gastrointestinal mucosal damage induced by different prostaglandin synthesis inhibitors (1987) (0)
Abolishment of rat striatal dopamine receptor supersensitivity by repeated doses of (-)-deprenyl (1988) (0)
ENDOGENOUS ANOREXIC SUBSTANCES (1984) (0)
New quinoline thioethers of their process for the preparation and pharmaceutical compositions containing them (1988) (0)
Pharmacology of azidomorphine (1978) (0)
The effects of azidoethylmorphine and related substances on cough and respiration in rats (1974) (0)
The morphine potentiating effect of Probon (1978) (0)
Rationale for (-) deprenyl (selegiline) therapy in parkinson's disease and alzheimer's disease (1995) (0)
The effects of p substituted amphetamines on the transmitter regulation in rat brain (1974) (0)
Differentiation between the two types of opiate receptors (A and B-receptors) with aid of N-substituted azidomorphines (1978) (0)
ACh turnover in isolated preganglionic nerves of the cat's sympathetic trunk (1978) (0)
[Investigation on tissue extracts with cardiotonic action. I. Cardiotonic effects of liver perfusate on isolated frog heart]. (1955) (0)
[Method for studying the depressive effects of tranquilizing substances on the central nervous system]. (1958) (0)
Reversal of shuttle-box deficit by 1-phenyl-2-propylaminopentane (PPAP) (1994) (0)
[Metabolism of para-bromomethamphetamine in the rat]. (1989) (0)
The inhibitory role of alpha receptors in intestinal motility (1976) (0)
Effect of azidomorphines on respiration (1977) (0)
Some new data on the metabolism of Probon (MZ 144) (1974) (0)
Possible role of prostaglandins in cardiac electrogenesis. (1974) (0)
In vivo antiapoptotic effect of (-)deprenyl and PPAP in rat mesencephalon (1997) (0)
The antitussive effect of azidomorphines (1977) (0)
ACh release from isolated sympathetic trunk of the cat (1978) (0)
The cardiotonic effect of disodium ethylenediamine tetraacetic-acid on the isolated frog's heart. (1957) (0)
The Antioxidant and Neuroprotective Effect of (-)-Deprenyl and their Relation to the Enhancer Effect (2012) (0)
A (-) deprenyl-derived new spectrum psychostimulant. (1990) (0)
2,3-polymethylene-4-oxo-4H-pyrido (1,2-a) pyrimidines and a process for producing same (1978) (0)
[Reactions of Halidor inside the body studied by means of positionally labeled radioisomers]. (1973) (0)
664 – EFFECT OF CELLULINE-A ON SODIUM MOVEMENTS ACROSS THE CARDIAC CELL MEMBRANE (1978) (0)
Novel fused pyrimidine derivatives, processes for their manufacture and their use as anti-inflammatory and coagulation of the blood-inflammatory drug (1976) (0)
Advances in pharmacological research and practice : proceedings of the 4th Congress of the Hungarian Pharmacological Society, Budapest, 1985 (1986) (0)
The selectivity of highly purified bovine liver angiohypotensin towards resistance vessels. (1990) (0)
Pharmacology of the 3-alkoxy-6-azidomorphines. Azidoethylmorphine, a new antitussive drug (1976) (0)
Symposium on drug induced metabolic changes (Hungarian) (1974) (0)
[Regulation of equilibrium of ions between cells and surrounding fluids in isolated frog hearts]. (1958) (0)
Synthetic tripeptides with anorexogenic effect. (1982) (0)
Schild analysis of the antihistamine effect of p-bromomethylamphetamine (V-111) (1977) (0)
Process for preparing compositions seasickness. (1987) (0)
421 – ANALYSIS OF THE EFFECTS OF AZIDOMORPHINE ON THE LONGITUDINAL AND CIRCULAR MUSCLE OF THE GUINEA PIG ILEUM (1977) (0)
Derivatives condensed pyrimidine and preparation of the body PROCESS (1977) (0)
1268 – CHARACTERISTICS OF CELLULINE-LIKE SUBSTANCES (1978) (0)
372 – THE EFFECT OF PARA-SUBSTITUTED AMPHETAMINES ON THE UPTAKE, RELEASE AND SYNTHESIS OF BRAIN BIOGENIC AMINES (1977) (0)
Effect of prostaglandin E1 on cholinergic neutrotransmission in brain tissue (1978) (0)
Analogifremgangsmaade for the preparation of 2,3-polymethylene-4-oxo-4H-pyrido or -azepinooe1,2-aaapyrimidiner or pharmaceutically acceptable acid addition salts or quaternary salts thereof (1978) (0)
Symposium on pharmacology of Vinca alkaloids. Volume 5 (1976) (0)
Depolarizing effect of PGE1 on taenia coli (1974) (0)
A new spectrum anxiolytic: 3-amino-4-ethylthio-7-Cl-quinoline. HCL (EGIS 5278). (1990) (0)
ACh accumulation proximal to nerve ligature (1977) (0)
2038 – DIRECT PROOF FOR THE SEROTONIN RELEASING EFFECT OF PARA-Br-METHYLAMPHETAMINE (1978) (0)
[Elaboration of a nonterminating conditioned protective motor reflex in rat]. (1954) (0)
[Regulation of ion balance between cells and surrounding fluids in isolated frog heart]. (1957) (0)
Comparative study of different narcotic analgesics (1974) (0)
2531 – PSYCHOPHARMACOLOGICAL ANALYSIS OF THE BEHAVIORAL EFFECTS OF MASSED ELECTROCONVULSIVE SHOCK IN RATS (1978) (0)
In vitro test on intestinal actions of azidomorphine and morphine (Hungarian) (1976) (0)
Symposium on Recent Trends in the Development of Drug Metabolism (1976) (0)
[Depression of the cerebrum in connection with active conditioned reflex activity]. (1957) (0)
1423 – BEHAVIORAL EFFECTS OF SELECTIVE MONOAMINE OXIDASE (MAO) INHIBITORS (1978) (0)
The dose-related hypotensive effect of highly purified bovine liver angiohypotensin in narcotized normotensive rats. (1990) (0)
Derivatives of dibenzo (bd) pyran, process for their preparation and pharmaceutical compositions containing them (1983) (0)
[Method for the investigation of the specific depressive effect of "tranquilizers" on the central nervous system. Part 2]. (1959) (0)
Effect of naloxone on ACh liberation from Auerbach's plexus of guinea pig ileum (1978) (0)
Subject Index Vol. 10, 1973 (1973) (0)
Beta-aminoketones, a new group of tranquilizers. (1961) (0)
Analysis of bovine liver angiohypotensin (AH) with HPLC purity on smooth muscle preparations (1992) (0)
Synergism of rimazolium and various antitussive agents (1976) (0)
[Modification of the tranquilizing effect of reserpine and an analysis of its central effect]. (1961) (0)
Facilitation of neuromuscular transmission in the guinea pig vas deferens preparation by celluline (1974) (0)
Influence of repeated administration of (-)deprenyl on serotonin syndrome in rats (1988) (0)
Comparison of in vivo and in vitro effects of norazidomorphine derivatives (1978) (0)
Effect of para-substituted amphetamines on the synaptosomal uptake of 3H-dopamine (1977) (0)
Metabolism of (-)deprenyl and its structural analogues (1988) (0)
631 – DOES THE B FORM SELECTIVE MONOAMINE OXIDASE INHIBITOR LOSE SELECTIVITY BY LONG TERM TREATMENT? (1978) (0)
[Analesic effect of atropine and its synergism with morphine and prostigmine]. (1951) (0)
Conversions of tosyl and mesyl derivatives of the morphine group. XIX. 'Azidomorphine' derivatives, III (1977) (0)
Dependence of the blocking action of PGE1 on sympathetic transmission on the degree and frequency of excitation (Hungarian) (1973) (0)
[Investigations on tissue extracts with cardiotonic action. II. Production of active extracts and their investigation on frog heart and on heart-lung preparation in dogs]. (1955) (0)
Symposium on Gastrin and Its Antagonists; First Congress of the Hungarian Pharmacological Society, Budapest, 1971, Vol. 3 (1973) (0)
MODIFICATION OF SYNAPTIC RECEPTOR FUNCTIONS BY (-) DEPRENYL (1984) (0)
A NEW MODEL FOR THE STUDY OF OPIATE B RECEPTORS: ISOLATED SPLENIC STRIPS OF THE CAT (1980) (0)
[Synergism of analgesics with choline]. (1952) (0)
OPIATE-A RECEPTORS RELATE TO CHOLINERGIC AND OPIATE-B RECEPTORS TO CATECHOLAMINERGIC NEURONS (1980) (0)
[Azidomorphins and homopyrimidazoles: a new attempt at finding an ideal analgesic]. (1978) (0)
133 – NEW SELECTIVE INHIBITORS OF MAO-B (1978) (0)
2169 – THE EFFECT OF PROSTACYCLIN (PGI2) ON ADRENERGIC RESPONSES OF ISOLATED ARTERIES AND VAS DEFERENS TO ELECTRICAL STIMULATION (1978) (0)
Of preparation for prevention against seasickness. (1987) (0)
CHARACTERISTICS OF OPIATE A AND B RECEPTORS STIMULATED OR INHIBITED BY INTRATHECALLY ADMINISTERED OPIATES IN THE RAT (1986) (0)
A Psychopharmacological Approach to a Possible Synaptic Memory Mechanism (1971) (0)
Study of the smooth muscle depolarizing action of PGE by the sucrose gap method (1976) (0)
Symposium on analgesics. Volume 1 (1976) (0)
[On the potentiating effect of reserpine in electroshock and its inhibition by 1-piperidinomethyl-2-tetralone]. (1960) (0)
CONVERSIONS OF TOSYL AND MESYL DERIVATIVES OF THE MORPHINE GROUP, XVII. ′AZIDOMORPHINE′ DERIVATIVES, I (1977) (0)
Azidoethylmorphine, a new potent, non-narcotic oral antitussive (1977) (0)
110 – THE EFFECTS OF DIFFERENT IONIC ENVIRONMENTS ON THE INTRACELLULAR CATION CONCENTRATIONS AND ON THE MEMBRANE POTENTIAL OF TAENIA COLI SMOOTH MUSCLE (1977) (0)
Garry Robert Van Petten (1936–1980) (1981) (0)
Comparison of the effects of (-)deprenyl, 1-phenyl-2-propyl-aminopentane (MK-306) and amphetamine on the striatal and limbic dopaminergic system. (1990) (0)
Analogifremgangsmaade for the preparation of 4-oxo-1,6,7,8-tetrahydro-4H-pyridooe1,2aaapyrimidinderivater (1976) (0)
The Lack of Change in Sensitivity of Dopamine and Muscarin Receptors After Repeated Treatment of(‐)Deprenyl (1992) (0)

This paper list is powered by the following services:

Jozsef Dr Knoll's Academic­Influence.com Rankings

Jozsef Dr Knoll's Degrees

Why Is Jozsef Dr Knoll Influential?

Jozsef Dr Knoll's Published Works

Published Works

Jozsef Dr Knoll's AcademicInfluence.com Rankings